HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Liberty Media invests in Borba

This article was originally published in The Rose Sheet

Executive Summary

QVC owner Liberty Media has acquired a stake in Borba LLC through its Liberty Interactive Group, the firm announces Aug. 15. The investment will enable Liberty to "participate in the value creation stemming from Borba's distribution through QVC." Terms of the deal were not disclosed. Borba, which sells beauty supplements and topical anti-aging products, debuted on QVC in May 2006. The company has sold almost $5 mil. worth of items on QVC since then, Liberty says. "BORBA is one of the most highly respected brands in this growing sector of the health and beauty business," QVC CEO Meade Rudasill says. Borba's items are also available at Sephora, Ulta, Macys and other national retailers...

You may also be interested in...



Borba Teams With Brewer To Market Drinkable Skin Care; QVC Owner Invests

Borba is looking forward to expanded distribution of its drinkable skin-care products and topical cosmeceuticals through a distribution agreement with Anheuser-Busch and the investment of Liberty Media Corporation, owner of QVC

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.

Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children

Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014918

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel